Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2002
10/24/2002US20020156295 Coordination catalyst containing ligand
10/24/2002US20020156292 Anticancer agents
10/24/2002US20020156285 Novel herbicides
10/24/2002US20020156284 Crystalline form of omeprazole
10/24/2002US20020156283 Psychological disorders; side effect reduction
10/24/2002US20020156115 Pyrazolylacetic acid derivatives
10/24/2002US20020156114 Antiinflammatory, antiarthritic agents
10/24/2002US20020156113 Farnesyl transferase inhibitors; anticancer agents
10/24/2002US20020156111 Substituted bicyclic compounds
10/24/2002US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002US20020156095 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc.
10/24/2002US20020156087 Pyrimidine or pyridine derivatives
10/24/2002US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002US20020155505 Methods for ligand discovery
10/24/2002US20020155153 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
10/24/2002EP1212298A4 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine
10/24/2002DE10119423A1 New cyanoimino- or nitroimino-substituted azole derivatives or analogs, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
10/24/2002DE10119204A1 Production of new or known 5-aryl-1,3,3-trimethyl-2-methylene-indoline derivatives useful in compositions for dyeing keratin and other fibers, especially human hair
10/24/2002DE10108481A1 Pyridylpyrimidine Pyridylpyrimidines
10/24/2002CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002CA2443734A1 Method of inhibiting adhesion formation
10/24/2002CA2443701A1 Triazinyl acrylamide derivatives as kinase inhibitors
10/24/2002CA2443699A1 Phenyl heterocyclyl ether
10/24/2002CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002CA2443366A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002CA2443229A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002CA2431553A1 Cxcr3 antagonists
10/23/2002EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002EP1250326A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
10/23/2002EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
10/23/2002EP1250047A2 Herbicidal composition
10/23/2002EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002EP1086095B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
10/23/2002EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002EP0979229B1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
10/23/2002EP0914118B1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/23/2002EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002EP0785191B1 Fused indan derivatives and salts thereof
10/23/2002EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002CN1376155A Thiourea and isothiourea derivatives for inhibiting RAS-transformed cell growth
10/23/2002CN1376147A 吡唑类衍生物 Pyrazole derivatives
10/23/2002CN1376064A Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties
10/23/2002CN1093125C Sulfamide-metalloprotease inhibitors
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002CN1093122C Piperazine derivatives as 5-HTIA antagonists
10/23/2002CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002US6469172 Process for the preparation of chemical compounds
10/22/2002US6469165 Process for preparation of polyaminotriazines
10/22/2002US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002US6469043 Antiangiogenic agent with antitumor, antimetastatic properties which shows high safety
10/22/2002US6469041 Certain pyrazole derivatives as corticotropin-releasing factor CRF1 ligands
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/22/2002US6469026 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis
10/22/2002US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6469023 Heterocyclic spiro-derivative
10/22/2002US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002US6469018 Compounds
10/22/2002US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002US6469006 Particularly for treating hiv infections
10/22/2002US6469003 Pyridazinone derivatives
10/22/2002US6468741 Electrochemiluminescent rhenium moieties
10/22/2002CA2227264C Amine acid salt compounds and process for the production thereof
10/17/2002WO2002081728A2 Quinoline inhibitors of hyak1 and hyak3 kinases
10/17/2002WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002WO2002081448A1 Benzamidine derivative
10/17/2002WO2002081445A1 Indolinones, substituted in position 6, and their use as kinase inhibitors
10/17/2002WO2002081444A1 1-indolyl derivatives, use thereof for production of medicaments, a method for production of said 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
10/17/2002WO2002081443A1 Novel guanidino compounds
10/17/2002WO2002081420A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
10/17/2002WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002WO2002080869A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
10/17/2002WO2002080853A2 Fused heterocyclic inhibitors of factor xa
10/17/2002WO2002068414A3 Analogs of thalidomide as potential angiogenesis inhibitors
10/17/2002WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002US20020151744 Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
10/17/2002US20020151724 Such as 1-((4-methoxybenzoyl-D-phenylglycinyl))-4-((isopropylamino)methyl)piperidine hydrochloride as anticoaggulants useful in the treatment of cardiovascular disorders such as thrombosis
10/17/2002US20020151718 Synthesis of pyrrole amides
10/17/2002US20020151715 Imidazole derivatives
10/17/2002US20020151714 One step dimerization forming 4-(8-fluoro-5,6-dihydro-11H-benzo-(5,6)-cyclohepta-(,2-b)pyridine-1-ylidene)-1-piperidine
10/17/2002US20020151712 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
10/17/2002US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002US20020151572 Nitric oxide synthase (NOS); alone or in combination with another active agent for the treatment of psoriasis, an antiinflammatory, an analgesic, a cognition enhancer or sleep disorder treatment
10/17/2002US20020151566 Phosphodiesterase 4 inhibitors
10/17/2002US20020151563 Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
1 ... 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 ... 1080